Published Mar 30, 2021

COVID-19 Chapter 15: Disease, Take 2

Explore the latest advancements in COVID-19 treatment and vaccine efficacy, with insights from experts on how drugs like remdesivir and dexamethasone are saving lives, and the impact of vaccines in curbing variants and severe disease, while Dr. Krutika Kuppalli and Dr. Jason Kindrachuk delve into the complexities and long-term effects of the virus.
Episode Highlights
This Podcast Will Kill You logo

Popular Clips

Episode Highlights

  • Therapeutics

    The evolution of therapeutic protocols for COVID-19 has significantly improved patient outcomes. highlights the advancements in treatment, noting that healthcare providers have become adept at managing critical cases through established protocols. These include the use of remdesivir and dexamethasone, which have become standard in treating hospitalized patients 1.

    We have remdesivir that has been the only therapeutic that has been approved by the FDA for the treatment of Covid-19.

    ---

    Despite these advancements, challenges remain in managing severe cases, particularly those with complications like superimposed bacterial infections 1.

       

    Critical Care

    Critical care for COVID-19 patients has seen notable improvements, especially in intensive care units. explains that protocols for intubation, mechanical ventilation, and proning have been refined, enhancing patient management 1.

    Our really wonderful critical care doctors have really gotten used to being able to manage them.

    ---

    These advancements have led to better supportive care, although the complexity of severe COVID-19 cases continues to pose significant challenges 1.

Related Episodes